Navigation Links
Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter
Date:12/6/2007

>In his settlement with the SLC, McGuire agreed to return over $320 million in options. He also volunteered to forego the full value of his fully-vested Supplemental Executive Retirement Plan (SERP) worth nearly $92 million and approximately $8.1 million of incentive compensation benefits in a deferred compensation plan. Along with the $198 million of repriced vested and unvested options last November, Dr. McGuire's actions remove any possible benefit he may have received as a result of the issues arising from the options program of the Company.

"Dr. McGuire deserves great credit for taking full responsibility to resolve the options dating issues at UnitedHealth Group," said David M. Brodsky, Dr. McGuire's attorney. "He called for the company investigation that helped identify the problems, proposed remedial actions to the Board to address them, resigned from the company to enable it to move forward, and more than paid back every penny at issue."

During his 17 year tenure, McGuire oversaw the transformation of UnitedHealth Group from a $600 million regional insurance company to a $70 billion global health services company. When McGuire took the helm in 1991, UnitedHealth Group served just over 1 million people. By 2006, that number had reached 50 million. UnitedHealth Group's performance during his tenure was spectacular, growing at a cumulative rate 30 times greater than the S&P average. Shareholders of UnitedHealth Group saw an 8,453 percent return on their investment under McGuire's leadership.

While CEO of the Company, UnitedHealth Group was recognized for its continuing innovation in the delivery of health care. These included expanded uses of data in decision-making, technology applications to improve efficiency and advance quality, the elimination of "gatekeeper" systems in favor of open access to doctors and nurses and new approaches to meeting the unique health care needs of older people and disadvantaged populations. Dr. McGuire
'/>"/>

SOURCE Latham and Watkins, LLP
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. iCAD to Present at William Blair & Company Small-Cap Growth Stock Conference
2. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
3. National Council of Negro Women (NCNW) Partners With Sherwin-Williams to Target Lead Risks in Neglected Housing
4. William Moore Appointed to IRIDEX Board of Directors
5. Exponent to Present at the Upcoming Sidoti & Company Investor Forum and William Blair Small-Cap Growth Stock Conference
6. AXA Equitable Life Insurance Co. Hires William McDermott to Lead Corporate Retirement Planning Business
7. AMICAS to Present at William Blair & Company Small Cap Growth Stock Conference
8. Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference
9. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
10. VNUS Medical Technologies Presents at William Blair Small-Cap Growth Stock Conference
11. Prominent Cosmetic Dentist Dr. William Hoskyns Joins Leading Atlanta Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... US Sports Football Camps expands its ... two non-contact specialty camps and one contact football camp. ... Training, located at Bowie State University and Riverdale Baptist ... skills, speed and strength of football athletes. The contact ... Marvin Graves, former quarterback in the Canadian Football League, ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 At ... company, announced today the launch of its powerful, ... on healthy and sustainable products at any retailer ... is exhibiting at Expo West Booth 6054. ... by gluten-free, Kosher, non-GMO, organic, Paleo, and vegan, ...
(Date:3/6/2015)... March 06, 2015 Johnson & Johnson ... verdict on March 5, 2015 in Superior Court in ... court documents, a jury of 12 awarded Mrs. Perry ... being implanted with an Ethicon TVT Abbrevo plastic sling ... and three women also awarded $5 million in punitive ...
(Date:3/6/2015)... 06, 2015 First Choice Emergency Room ... new facility is located at 13351 W. Bowles Avenue, Littleton, ... team is ready 24-7 to provide the highest quality emergency ... Medical Director of First Choice Emergency Room Littleton. ... the South Metro Denver Chamber of Commerce and a medical ...
(Date:3/6/2015)... GA (PRWEB) March 06, 2015 ... announced the release of a Clostridium Difficile (C ... providers. The C Diff use case is the ... that span hospital acquired infections, chronic conditions, and ... platform, the C Diff solution flags at risk ...
Breaking Medicine News(10 mins):Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 3Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2
... Breast Cancer Survivors , Breast cancer survivors, ... death from non-cancer causes than from breast cancer. ... are surviving longer, and many are dying of ... and colleagues with the National Cancer Institute of ...
... to treatment than those with HPV-negative tumors , , TUESDAY, ... patients whose tumors test positive for human papillomavirus (HPV) ... than those who test negative, a new study says. ... be responsible for most cervical cancers, has recently been ...
... Safety ... Net Partnerships, OAKLAND, Calif., ... 778 community benefit grants,totaling more than $29 million. The charitable contributions ... it,serves. Funds were pledged or paid in each of Kaiser Permanente,s ...
... Northwestern Memorial,HealthCare, corporate parent of Northwestern Memorial ... new members to the Northwestern,Memorial Foundation,s Boards of ... currently serves as president of the Friends of ... Northwestern Memorial Hospital,s,Campaign Steering Committee. Gordon is chairman ...
... Other Strength Patches (12.5, 50, 75 and 100 ... PriCara(TM), Division of,Ortho-McNeil-Janssen Pharmaceuticals, Inc. said today ... transdermal system) CII,patches sold by PriCara in the ... by Sandoz Inc. in the United States are ...
... Group Improve Claims Processing, ... Appointment Scheduling and Patient Statements, BIRMINGHAM, Ala., ... agreement with Huntsville Pediatric Associates,to provide MDr PracticeManager(TM), ... appointment scheduling, medical,billing, electronic claims submission, payment and ...
Cached Medicine News:Health News:Other highlights in the Feb. 12 JNCI 2Health News:Other highlights in the Feb. 12 JNCI 3Health News:Other highlights in the Feb. 12 JNCI 4Health News:Kaiser Permanente Approves $29 Million in Community Benefit Grants 2Health News:Kaiser Permanente Approves $29 Million in Community Benefit Grants 3Health News:Northwestern Memorial HealthCare and Northwestern Memorial Foundation Elect New Members to Board of Directors 2Health News:PriCara(TM) Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches 2Health News:Huntsville Pediatric Associates Selects DST Health Solutions' Practice Management Solution for Billing, Accounts Receivable 2
(Date:3/6/2015)... CITY, Calif. , March 6, 2015  Abaxis, ... company manufacturing point-of-care instruments and consumables for the medical, ... services to the veterinary and research markets in ... the Center for Veterinary Biologicals of the U.S. Department ... Test Kit for the detection of   A. phagocytophelium ...
(Date:3/6/2015)... SAN FRANCISCO, Calif. , March 6, 2015 /PRNewswire/ ... today announced new data demonstrating that diagnostic tests that ... thyroid nodules can dramatically reduce the specificity of test ... which benign nodules are erroneously diagnosed as cancerous. In ... actually miss half of the malignancies leading to "false ...
(Date:3/6/2015)... 2015 UNICANCER pourra ... pouvant bénéficier de l,innovation thérapeutique.   ... de contenu pour l,Entreprise, annonce que sa solution ... Centres de lutte contre le cancer (CLCC), comme ... ConSoRe (Continuum Soin-Recherche) conduit par la société de ...
Breaking Medicine Technology:Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 2Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 2Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 4Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 5Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 6TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 2TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 3TEMIS et SWORD accompagnent UNICANCER pour accélérer la recherche par l'analyse sémantique des dossiers patients 4
... , COCKEYSVILLE, Maryland, November 2 ... Iron Phosphate Technology,to New Levels. , ... high-tech,batteries for industry, has expanded its range of lithium technologies ... phosphate,cell on the market. These large cells are designed for ...
... Shire plc (LSE: SHP, Nasdaq: SHPGY ... a major medical meeting from a Phase IIIb study of ... (methylphenidate transdermal system) in adolescents aged 13 to 17 years ... In addition, data regarding the pharmacokinetic profile of Daytrana in ...
Cached Medicine Technology:Saft Develops Super-Phosphate(TM) Technology for Rigorous Defense Applications 2Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 2Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 3Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 4Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 5Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 6Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD 7
Kerrison (Micro) Laminectomie Rongeur, with ejector. 18 cm - 7 1/8, with thick footplate, small handle, 90 up-cutting, jaws 2 mm wide....
... ValveTM, Hakim, H-V Lumbar Valve ... for meeting the complex demands ... response causes the valve to ... present, eliminating the need for ...
Codman Hakim Programmable valve cylindrical offers the ability to optimize the opening pressure of a shunt system before and after implantation. A shunted patient's condition will often change over t...
Leadpoint Micro-Electrode Recording...
Medicine Products: